EPO aggregation has been reported that is critically connected to the immunochemistry of rhEPO preparation; it was specifically responsible for the development of EPO antibody-mediated deadly disease condition called pure red cell aplasia (PRCA) [60,61,62]. The gene discussed is EPO; the disease is Pure red cell aplasia.